Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 408,561 | 328,508 | 316,193 | 492,600 | 670,408 |
| Marketable Securities | 109,342 | 124,415 | 118,681 | 302,693 | 322,399 |
| Receivables | 74,528 | 91,201 | 51,797 | 43,495 | 46,034 |
| Inventories | 12,795 | 19,487 | 21,023 | 16,700 | 12,760 |
| Income taxes - deferred | 79,114 | 84,038 | 82,661 | 80,966 | 89,983 |
| TOTAL | $714,540 | $677,081 | $618,558 | $970,286 | $1,169,031 |
| Non-Current Assets | |||||
| PPE Net | 245,667 | 249,017 | 254,361 | 254,676 | 140,127 |
| Investments And Advances | 335,371 | 327,946 | 308,277 | 361,614 | 295,950 |
| Intangibles | 323,454 | 329,468 | 334,676 | 337,901 | 305,651 |
| Other Non-Current Assets | 48,418 | 42,993 | 36,078 | 36,321 | 42,796 |
| TOTAL | $952,910 | $949,424 | $933,392 | $990,512 | $784,524 |
| Total Assets | $1,667,450 | $1,626,505 | $1,551,950 | $1,960,798 | $1,953,555 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,845 | 6,673 | 9,900 | 14,831 | 12,596 |
| Accrued Expenses | 119,154 | 119,638 | 99,019 | 116,092 | 111,596 |
| TOTAL | $152,244 | $152,374 | $144,465 | $156,840 | $152,438 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 23,233 | 20,547 | 22,656 | 23,493 | 25,099 |
| Other Non-Current Liabilities | 45,985 | 43,412 | 39,950 | 39,286 | 32,685 |
| TOTAL | $65,344 | $65,598 | $61,685 | $60,725 | $50,055 |
| Total Liabilities | $217,588 | $217,972 | $206,150 | $217,565 | $202,493 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 101,770 | 101,728 | 101,473 | 102,436 | 104,711 |
| Common Shares | 102 | 102 | 102 | 103 | 105 |
| Retained earnings | 1,408,587 | 1,378,371 | 1,316,461 | 1,709,479 | 1,657,997 |
| Other shareholders' equity | 24,062 | 26,635 | 29,237 | 33,651 | 27,991 |
| TOTAL | $1,449,862 | $1,408,533 | $1,345,800 | $1,743,233 | $1,751,062 |
| Total Liabilities And Equity | $1,667,450 | $1,626,505 | $1,551,950 | $1,960,798 | $1,953,555 |